Solix Technologies, Inc.

AI used to be 1M times slower than the human brain. Today? That gap has vanished to just 20x. The race to build AI is over. The race to govern it has begun. Our VP of Engineering, Suresh M., sat down with TALRadio English to break down the 2026 Reality: Subject Matter is the New Gold: Tech skills are now just the "entry fee." Your industry expertise is the real value. Fluid Intelligence: Adaptability isn't just a soft skill it’s your greatest competitive advantage. The Human Guardrail: AI is the engine, but humans must be the steering wheel. The challenge isn't just getting better it’s staying in control. Watch the full interview in the comments! #EnterpriseAI #FutureOfWork #SovereignAI #DataGovernance #Solix #Solix #EnterpriseAI #DataGovernance #AIGovernance, #SoverignAI #AIReadiness #Application Retirement

AI is moving fast, but before it can solve anything for your business, you have to address the roadblocks: Data residency gaps, Shadow AI silos, and the very real risks of Law 25 compliance. With Solix, sovereignty is built-in. Gain 100% visibility on Canadian soil and automate your masking, sovereign archiving, and AI governance. By the time you hit "Run," your data is already compliant protecting your enterprise from massive regulatory fines. When your data is secure, innovation has no limits. Read the full breakdown in our latest blog, "The Sovereignty Imperative," authored by Robert (Bob) Wright, VP of Sales Canada: https://lnkd.in/gdvSRGHA #DataSovereignty #Law25 #EnterpriseAI #DataPrivacy #DataGovernance #SolixTechnologies #CanadianTech #SolixAI

💫 Back from 11 days in London with our new Solix Europe sales team, and I'm excited about what's ahead. This team is exceptional! Over the course of the week, I watched a group of seasoned, sharp, and genuinely collaborative professionals come together with real momentum: • Matthew Long, VP of Sales Europe, whose leadership is already the foundation of what we're building. Matt contributed greatly to the hiring for this team with an eye for quality, experience, and cultural fit, and his direct, hands-on approach to onboarding and training last week was a masterclass. Europe is in strong hands. • Mike Hamm, Senior Enterprise Sales Director and one of Solix's most consistent top performers. Based in London, Mike spent the week coaching and mentoring the new reps, sharing the playbook he's refined over years of enterprise wins. Watching him pay it forward to the team was one of the highlights of the trip. • Ravi Summan, Strategic Account Director, bringing deep enterprise experience and a consultative approach that European buyers are going to respond to. I had the pleasure of meeting with one of Ravi's first potential clients while in London last week. • Surbhi Maghan, Strategic Account Director, sharp, strategic, and already thinking several moves ahead on her target accounts. • Jonathan Dominic, Strategic Account Director, is a driven, high-integrity professional who I'm confident is going to put up big numbers. By the end of the week, this team wasn't just trained. They were ready to go. 💡 The timing couldn't be better for European enterprises: → GDPR compliance is not optional → The EU AI Act goes live this August, and most organizations are not yet ready → AI initiatives are accelerating faster than the data foundations required to support them Solix is uniquely positioned to solve all three. Our enterprise data management platform, combined with our new AI Data Readiness Services, gives European organizations a single solution to stay compliant, govern their data with confidence, and make it truly AI-ready. We'll also be extending our outstanding global channel partner network deeper into the European market, expanding reach, accelerating growth, and ensuring European customers get the same level of partner-enabled delivery we've built elsewhere around the world. To Matt, Mike, Ravi, Surbhi, and Jonathan: thank you for the warm hospitality, the sharp conversations, and the energy you brought every single day. I left London more confident than ever that Solix Europe is going to set the standard for what "AI-ready, compliant data" looks like on the continent. #Solix #EnterpriseAI #GDPR #EUAIAct #DataCompliance #AIReadiness

You cannot just archive data and keep it somewhere else. The compliances are mandatory. For both generic and innovator pharmaceutical companies, managing data is a complex balancing act. At Solix Empower, Chitti Babu, Group CIO of Aurobindo Pharma, took the stage to highlight the heavy regulatory pressures of Enterprise Archiving. Key takeaways from his session: - FDA Mandates: The requirement to keep 10 years of data accessible online. - Pharmacovigilance: Why market complaints mean you might need to pull data older than 10 years at a moment's notice. - The DPDP Act: Navigating consent, retention periods, and avoiding massive financial penalties. A powerful reminder that in highly regulated industries, your data architecture must be built for compliance. #SolixEmpower #PharmaTech #AurobindoPharma #DataGovernance #FDACompliance #EnterpriseArchiving #HealthTech

Canadian financial institutions are stuck in the "Reluctance Gap" navigating AI pilots without the necessary foundational AI-readiness. It’s time to move from experimentation to scalable intelligence. Read the full breakdown by Robert (Bob) Wright here: https://lnkd.in/gtNpx282 #EnterpriseAI #CanadianFinance #DataGovernance #AIReadiness #Solix #SolixEAI

90% of clinical trials fail. And the 10% that succeed? They take an average of 15 years and $1.5 Billion to develop. During a recent sit-down, Murali Krishnam, VP of Product Strategy for BioPharma Enterprise AI at Solix Technologies, Inc., broke down the staggering math behind modern drug discovery and why the traditional pharmaceutical model is facing an unsustainable bottleneck. Watch the breakdown below. 👇 (Link to the full Enterprise AI for Pharma discussion in the comments!) #LifeSciences #Pharma #DrugDiscovery #AIinHealthcare #DataOps #Solix

AI is more than a research project it’s about operational results. 🚀 At #SOLIXEmpower, Vikram Kumar (CEO, MultiplierAI) shared how Agentic AI Ops is transforming Life Sciences. By moving beyond just 'answering questions' to 'executing tasks,' enterprises can finally reconcile complex data sources and drive real KPIs. Is your AI strategy built for research, or for operations? #AgenticAI #DataOps #LifeSciences #DigitalTransformation #Solix

Is your enterprise data truly AI-ready, or is it trapped in silos? To leverage GenAI effectively, organizations need more than just data; they need a unified foundation. The Solix Common Data Platform (CDP) provides a single, scalable solution to ingest, archive, and govern every data type structured and unstructured. With Solix CDP, you get: ✅ Unified View: Seamlessly manage all your enterprise data. ✅ Enterprise-Grade Governance: Secure, compliant, and audit-ready. ✅ GenAI Foundation: The critical first step toward building reliable AI models. Stop managing silos. Start governing at scale. #DataManagement #BigData #EnterpriseIT #GenAI #DataGovernance #SolixCDP #InformationLifecycle

Can AI truly unlock the secret to curing cancer? 🧬 Murali Krishnam, VP of Product Strategy For BioPharma Enterprise AI at Solix, discusses the powerful "inflection point" where AI breakthroughs meet scientific discovery. By creating a force multiplier, AI is enabling the development of personalized medicines faster and more affordably than ever before. With thousands of genetic mutations, traditional medicine struggles to scale but AI can. 👇 Check out the full discussion on how AI is reshaping Life Sciences in the comments! Learn more about Solix EAI pharma : https://lnkd.in/gKdXrgCQ.. #AI #LifeSciences #CancerResearch #HealthcareInnovation #HealthTech #Solix #DigitalTransformation #PrecisionMedicine #SolixEAIPharma

Most Pharma AI initiatives stall not because of weak algorithms, but due to fragmented data. In his latest piece, Murali Krishnam explains how Knowledge Graphs are becoming the "living map" for biological and clinical insights moving the industry from "what" to "why." Key highlights: 🔹 Moving beyond "data graveyards" to contextual intelligence. 🔹 Building trust with explainable and auditable AI. 🔹 Achieving "Predictive Velocity" for faster drug discovery. Read the full article by Murali Krishnam, VP of Product Strategy, Enterprise Pharma AI at Solix Technologies: Link: https://lnkd.in/gACFR7BZ #PharmaAI #KnowledgeGraphs #DrugDiscovery #DataGovernance #Solix #EnterpriseAI #AIStrategy #DataPrivacy #FinTech #HealthTech #Solix"